Australia markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.4250+0.0250 (+0.74%)
At close: 04:00PM EDT
3.4500 +0.03 (+0.73%)
After hours: 05:46PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.35-0.27-1.43-1.12
Low estimate-0.35-0.27-1.43-1.12
High estimate-0.35-0.27-1.43-1.12
Year ago EPSN/A-0.4-4.2-1.43
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid Date30/12/202230/03/202330/12/2023
Est. EPSN/A-0.67-0.62-0.23
Actual EPSN/A-0.4-2.87-0.22
DifferenceN/A0.27-2.250.01
Surprise %N/A40.30%-362.90%4.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.35-0.27-1.43-1.12
7 days ago-0.35-0.27-1.43-1.11
30 days ago-0.35-0.27-1.44-1.12
60 days ago-0.090-0.34-0.41
90 days ago-0.090-0.34-0.41
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACSTIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.32.50%N/AN/AN/A
Current year66.00%N/AN/AN/A
Next year21.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A